A detailed history of Means Investment Co., Inc. transactions in Eli Lilly & CO stock. As of the latest transaction made, Means Investment Co., Inc. holds 2,973 shares of LLY stock, worth $2.64 Million. This represents 0.33% of its overall portfolio holdings.

Number of Shares
2,973
Previous 3,282 9.41%
Holding current value
$2.64 Million
Previous $2.55 Million 5.41%
% of portfolio
0.33%
Previous 0.33%

Shares

23 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 19, 2024

SELL
$724.87 - $909.04 $223,984 - $280,893
-309 Reduced 9.41%
2,973 $2.69 Million
Q1 2024

Apr 17, 2024

SELL
$592.2 - $792.28 $1,776 - $2,376
-3 Reduced 0.09%
3,282 $2.55 Million
Q4 2023

Jan 25, 2024

SELL
$525.19 - $619.13 $43,065 - $50,768
-82 Reduced 2.44%
3,285 $1.91 Million
Q3 2023

Oct 25, 2023

SELL
$434.7 - $599.3 $104,328 - $143,832
-240 Reduced 6.65%
3,367 $1.81 Million
Q2 2023

Jul 31, 2023

BUY
$350.74 - $468.98 $21,044 - $28,138
60 Added 1.69%
3,607 $1.69 Million
Q1 2023

May 08, 2023

SELL
$310.63 - $364.82 $66,164 - $77,706
-213 Reduced 5.66%
3,547 $1.22 Million
Q4 2022

Jan 27, 2023

BUY
$321.55 - $374.67 $17,685 - $20,606
55 Added 1.48%
3,760 $0
Q3 2022

Oct 17, 2022

SELL
$296.48 - $337.87 $8,894 - $10,136
-30 Reduced 0.8%
3,705 $1.2 Million
Q2 2022

Jul 21, 2022

BUY
$278.73 - $327.27 $73,305 - $86,072
263 Added 7.57%
3,735 $1.21 Million
Q1 2022

Apr 26, 2022

BUY
$234.69 - $291.66 $11,030 - $13,708
47 Added 1.37%
3,472 $994,000
Q4 2021

Feb 14, 2022

BUY
$224.85 - $279.04 $43,396 - $53,854
193 Added 5.97%
3,425 $946,000
Q3 2021

Nov 12, 2021

SELL
$221.6 - $272.71 $5,540 - $6,817
-25 Reduced 0.77%
3,232 $747,000
Q2 2021

Aug 10, 2021

BUY
$180.55 - $233.54 $26,179 - $33,863
145 Added 4.66%
3,257 $748,000
Q1 2021

Apr 05, 2021

BUY
$164.32 - $212.72 $7,230 - $9,359
44 Added 1.43%
3,112 $581,000
Q4 2020

Feb 12, 2021

BUY
$130.46 - $172.63 $97,714 - $129,299
749 Added 32.3%
3,068 $622,000
Q3 2020

Nov 09, 2020

BUY
$146.22 - $169.13 $1,900 - $2,198
13 Added 0.56%
2,319 $331,000
Q2 2020

Aug 13, 2020

SELL
$136.42 - $164.18 $409 - $492
-3 Reduced 0.13%
2,306 $347,000
Q1 2020

Apr 23, 2020

BUY
$119.05 - $147.35 $238 - $294
2 Added 0.09%
2,309 $362,000
Q4 2019

Jan 21, 2020

BUY
$106.92 - $132.43 $213 - $264
2 Added 0.09%
2,307 $322,000
Q3 2019

Nov 05, 2019

SELL
$106.79 - $116.16 $42,502 - $46,231
-398 Reduced 14.72%
2,305 $261,000
Q2 2019

Aug 07, 2019

BUY
$110.79 - $129.32 $221 - $258
2 Added 0.07%
2,703 $306,000
Q1 2019

Apr 16, 2019

SELL
$111.31 - $131.02 $25,712 - $30,265
-231 Reduced 7.88%
2,701 $350,000
Q4 2018

Apr 16, 2019

BUY
$105.9 - $118.64 $310,498 - $347,852
2,932 New
2,932 $339,000

Others Institutions Holding LLY

About ELI LILLY & Co


  • Ticker LLY
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 950,174,976
  • Market Cap $843B
  • Description
  • Eli Lilly and Company discovers, develops, and markets human pharmaceuticals worldwide. It offers Basaglar, Humalog, Humalog Mix 75/25, Humalog U-100, Humalog U-200, Humalog Mix 50/50, insulin lispro, insulin lispro protamine, insulin lispro mix 75/25, Humulin, Humulin 70/30, Humulin N, Humulin R, and Humulin U-500 for diabetes; and Jardiance, T...
More about LLY
Track This Portfolio

Track Means Investment Co., Inc. Portfolio

Follow Means Investment Co., Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Means Investment Co., Inc., based on Form 13F filings with the SEC.

News

Stay updated on Means Investment Co., Inc. with notifications on news.